Novartis Ag (NVS) Revenue Growth (5y) (2014 - 2025)

Novartis Ag (NVS) Revenue Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 4.37%
Jun 30, 2024 1.24%
Dec 31, 2023 149.93%
Jun 30, 2023 -2.76%
Mar 31, 2023 8.85%
Dec 31, 2022 4.69%
Sep 30, 2022 4.21%
Jun 30, 2022 0.87%
Dec 31, 2021 -12.04%
Sep 30, 2021 3.86%
Jun 30, 2021 141.11%
Mar 31, 2021 1,615.73%
Dec 31, 2020 30.07%
Sep 30, 2020 27,635.87%
Jun 30, 2020 3,616.65%
Mar 31, 2020 1,639.65%
Jun 30, 2019 4,054.95%
Mar 31, 2019 1,851.63%
Dec 31, 2018 1,183.33%
Jun 30, 2018 3,070.08%